Evaluation of the psychometric properties of the BCPT Symptom Checklist with a sample of breast cancer patients before and after adjuvant therapy
Authors:
- 24 August 2011
- journal article
- research article
- Published by Wiley in Psycho-Oncology
- Vol. 20 (9) , 961-968
Abstract
Objective: The purpose of this analysis was to provide psychometric information related to the Breast Cancer Prevention Trial (BCPT) Symptom Checklist in women with breast cancer prior to the initiation of adjuvant therapy and 6 months post‐initiation of therapy.Methods: This investigation was a secondary analysis of baseline data from the Anastrozole Use in Menopausal Women (AIM) Study (R01 CA 107408). The data used in this study were obtained from women diagnosed with Stage I, II, and IIIa breast cancer and who received adjuvant therapy that included chemotherapy alone, anastrozole alone, and chemotherapy plus anastrozole. Data were examined before adjuvant therapy (n=278), and at 6 months post‐adjuvant therapy (n=195). Construct validity was examined through exploratory and confirmatory factor analysis (CFA), and the internal consistency of each resulting subscale was computed. Discriminant validity evidence was obtained by correlating BCPT subscales with subscales from the MOS SF‐36.Results: A seven‐factor structure was extracted from the 42 items at baseline; an eight‐factor structure was found using 6‐month data. CFA was performed to compare the baseline and 6‐month models as well as an eight‐factor model recommended by Cella et al. Findings revealed that the two eight‐factor models best represented the data. Low negative correlations with the subscales of the MOS SF‐36 provided discriminant validity evidence.Conclusion: This analysis provides evidence for the reliability, discriminant validity, and factor structure of the BCPT Symptom Checklist. Further testing of this instrument is needed to confirm the factor structure of this measure. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 19 references indexed in Scilit:
- The impact of cognitive function on medication management: Three studies.Health Psychology, 2010
- Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancerMenopause, 2007
- Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife womenBreast Cancer Research and Treatment, 2007
- Menopausal-type symptoms in young breast cancer survivorsAnnals of Oncology, 2006
- Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivorsPsycho-Oncology, 2006
- Fatigue in long‐term breast carcinoma survivorsCancer, 2006
- The BCPT Symptom Scales: A Measure of Physical Symptoms for Women Diagnosed With or at Risk for Breast CancerJNCI: Journal of the National Cancer Institute, 2005
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- An Index of Factorial SimplicityPsychometrika, 1974
- Coefficient Alpha and the Internal Structure of TestsPsychometrika, 1951